Cloud-based Regulatory Information Management system purpose-built for pharmaceutical regulatory submissions, health authority interactions, and product registration lifecycle management.
Veeva Vault RIM is a multi-tenant SaaS regulatory information management suite for global biopharma and medtech regulatory affairs, quality, and IT teams. The suite comprises four core applications - Vault Registrations, Vault Submissions, Vault Submissions Publishing, and Vault Submissions Archive - sharing a single relational object model spanning products, registrations, events, submissions, content plans, correspondence, commitments, and IDMP elements in one Vault. The RIM data model is built against ISO IDMP and IMDRF UDI standards.
A single data-and-content model spans the platform, with prebuilt Veeva Connections linking Vault RIM to Vault Quality (change-control to variation), Vault Clinical Operations (eTMF/CTMS data flow), Vault PromoMats (FDA Form 2253/AdPromo), and Vault Safety. For customers already on Vault Quality or Vault Clinical, the marginal cost of adding Vault RIM is license and configuration, since the data-sharing Connections are pre-built.
Veeva publishes that 19 of the top 20 biopharma companies and 450+ life-sciences organizations were using Vault RIM as of September 2025, with 85+ on Vault Submissions Publishing specifically. Adoption grew from 55 customers in 2016 to 150+ in 2019, 250+ in February 2021, 350+ in October 2022, 400+ in mid-2023 (16 of the top 20), and 450+ by September 2025 (19 of the top 20). Veeva's aggregate disclosed customer count across all products is 1,552 as of FY2026 (year ended January 31, 2026), including 1,196 in R&D & Quality Cloud.
Independent buyer-fit analysis names Vault RIM's best-fit buyers as top-50 biopharma already running Vault Quality, Vault Clinical, or Vault Safety; mid-cap pharma with a global registration footprint and at least 25 regulatory affairs users; and biotechs preparing for a first BLA or MAA, where inspection-ready validated submissions and IDMP/SPOR readiness are gating dependencies. The same analysis names the worst-fit buyers as a sub-10-user biotech with a single product and no near-term IDMP exposure, medtech-only organizations already running a non-Veeva quality management system, where UDI and EUDAMED workflow support is weaker, and buyers requiring an on-premise or non-AWS sovereign-cloud deployment, since Vault RIM is AWS-only.
Vault RIM does not include built-in country-level regulatory intelligence content.
Pharmaceutical Edition
Entire platform purpose-built for pharmaceutical regulatory operations - industry-specific by design
Core Capabilities
FDA & GxP Compliance
International Standards
Security Certifications
Data Integrity & Validation
Multi-tenant SaaS on the Veeva Vault Platform, hosted on AWS as the primary cloud infrastructure provider. A June 2025 Veeva-AWS relationship expansion covers 50+ Vault applications on AWS. The platform is partitioned into PODs across US East/West, Europe, and Asia-Pacific regions, enabling customer-selectable data residency. Sovereign-cloud availability (EU sovereign, China, India, GovCloud) for Vault RIM specifically is undisclosed. Vault is AWS-only; Azure and other clouds are not options. SAML 2.0 SSO and SCIM provisioning are supported, with Okta and AzureAD commonly deployed. Access is browser-based; whether a native mobile app exists for Vault RIM specifically is undisclosed.
A REST API covers objects and documents, and the Vault Direct Data API (introduced 2025) provides bulk data extraction for analytics and AI use cases. Veeva offers a Java SDK for custom logic, which falls under GAMP 5 Category 5. Veeva-delivered Connections handle Quality-RIM and Clinical-RIM internally; SAP product master integration runs through partner-built connectors. Webhooks, GraphQL, and named connectors for SAP, Oracle, and Workday are not first-party - they are typically built via Vault APIs by integrators such as Accenture, Deloitte, USDM, Valiance, Indegene, and ProductLife.
Supported data standards include eCTD 1.x-4.0 (continuous publishing of v4.0 is ready), the DIA EDM Reference Model, IDMP/SPOR (with an FHIR field for PMS response handling), xEVMPD, and IMDRF UDI. Veeva reports 99.5%+ uptime and that 97% of customer Vaults upgrade in 10 minutes.
No list price is published: Veeva negotiates all pricing under NDA. The subscription is a base license per Vault application plus named-user licenses; each application (Registrations, Submissions, Submissions Publishing, Submissions Archive) is licensed separately, so a user needing access to multiple applications consumes multiple licenses. No perpetual license is sold. There is no public free trial; product demos are gated through sales contact.
Independent industry analysis, not vendor-confirmed, reports deal sizes by segment: $15K+ to $45K+/year on RIM licenses for 1-3 RA users at a small biotech, $45K+ to $120K+ for 3-8 users at a mid-stage company, and enterprise multi-application deployments commonly crossing the $500K+/year "redline" before negotiated discounts. The same analysis reports per-user economics of $50+ to $200+ per user per month for full-feature users.
Setup and validation-support fees are typically one-time professional-services line items: $15K+ to $75K+ for IQ/OQ/PQ services, $10K+ to $50K+ for data migration, and $5K+ to $25K+ for global regulatory template configuration. Multi-year contracts (three-year terms) are standard and unlock volume tiering. Bundled deals with Vault Quality and Vault Clinical achieve better effective per-user RIM pricing.
Typical implementation takes 3-6 months for mid-cap Submissions or Registrations rollouts using Veeva Professional Services or a strategic systems integrator (Accenture, Deloitte, IQVIA, USDM, Indegene, ProductLife, BASE Life Science), and 12+ months for top-20 pharma global rollouts that consolidate multiple legacy systems. In one documented case, 1,100 licenses, 6,100 registered packages, 4,300 regulatory objectives, and 51,000 source documents (100 GB) migrated from FirstDoc and file shares in approximately six months under TSA pressure. Veeva reports that one top-20 pharma harmonized 19 million data points and unified 65+ legacy systems on Vault RIM.
Services included with the license are limited to Veeva-executed IQ/OQ for the platform and ComplianceDocs access. Configuration, validation (PQ), data migration, and training are priced separately and are typically the dominant first-year cost. Migration tooling exists for data coming from Documentum, FirstDoc, OpenText, eCTDXPress, Lorenz docuBridge, and SharePoint, with Valiance Partners and other certified migration vendors offering purpose-built tooling.
Common implementation pitfalls include under-resourced configuration that leads to usability issues, submission template and eCTD metadata mapping for complex affiliate structures, SAP/ERP product master integration timelines, and over-validation of low-risk auto-on features, which creates a maintenance burden across Veeva's three-times-a-year release cadence.
Anonymous feedback from pharmaceutical professionals using this solution
4.6 out of 5
Based on 11 verified reviews
What Users Like
Users cite the depth of audit-trail and dossier-management capabilities, configurability without custom code, and the integration value of the Vault platform. G2 feature scores: Ease of Use 9.2, Meets Requirements 9.4, Audit Trails 10.0, Dossier Management 9.9, Quality of Support 8.9, Product Direction 10.0. Roche credits Active Dossier with "transparency of our data that we have not had before" (Lynsey Geldeard, Regulatory Program Director, Roche). Ionis reports that the unified system means "the left hand knows what the right hand is doing" (Christie Hamel, Director, Ionis). Customers cite stability handling large documents and the breadth of pre-built features.
What Users Dislike
Users report concerns about cost for emerging-stage companies, a steep administrator learning curve, search efficacy when content is poorly tagged, and Veeva support response times for complex tickets. A Software Advice review states: "It can be a bit expensive for companies that are just starting off or are small... if someone is not trained well, they can definitely make major issues in the system and support from Veeva may take too long to fix certain large issues." UI bugs in search behavior are reported, and platform breadth demands process discipline: "If content is poorly tagged, search efficacy drops. Automated classification is improving but still requires process discipline." Independent buyer-fit analysis flags vendor-dependency risk: Vault RIM integrates most readily with other Veeva applications, and pairing it with non-Veeva quality or clinical platforms raises integration friction for organizations standardizing on those platforms.
Help the community
Share your experience with Veeva Vault RIM anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section